{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:41:31Z","timestamp":1760550091683,"version":"3.37.3"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,8,9]],"date-time":"2016-08-09T00:00:00Z","timestamp":1470700800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s10792-016-0315-3","type":"journal-article","created":{"date-parts":[[2016,8,9]],"date-time":"2016-08-09T05:32:13Z","timestamp":1470720733000},"page":"619-626","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Does the intraocular pressure-lowering effect of prostaglandin analogues continue over the long term?"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3628-547X","authenticated-orcid":false,"given":"Caner","family":"KARA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emine Malko\u00e7","family":"\u015eEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kadriye Ufuk","family":"ELG\u0130N","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurtulu\u015f","family":"SERDAR","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pelin","family":"YILMAZBA\u015e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,9]]},"reference":[{"issue":"4","key":"315_CR1","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/archopht.122.4.615","volume":"122","author":"L Pizzarello","year":"2004","unstructured":"Pizzarello L, Abiose A, Ffytche T, Duerksen R, Thulasiraj R, Taylor H, Faal H, Rao G, Kocur I, Resnikoff S (2004) VISION 2020: the right to sight: a global initiative to eliminate avoidable blindness. Arch Ophthalmol 122(4):615\u2013620. doi: 10.1001\/archopht.122.4.615","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"315_CR2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0002-9394(98)00223-2","volume":"126","author":"Group, Collaborative Normal-Tension Glaucoma Study.","year":"1998","unstructured":"Group, Collaborative Normal-Tension Glaucoma Study. (1998) Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol 126(4):487\u2013497","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"315_CR3","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0002-9394(98)00272-4","volume":"126","author":"D Anderson","year":"1998","unstructured":"Anderson D, Drance SM, Schulzer M (1998) The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol 126(4):498\u2013505","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"315_CR4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","volume":"130","author":"AGIS Investigators","year":"2000","unstructured":"AGIS Investigators (2000) The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 130(4):429\u2013440","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"315_CR5","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archopht.120.6.701","volume":"120","author":"MA Kass","year":"2002","unstructured":"Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK, 2nd, Wilson, Gordon MO (2002) The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120(6):701\u2013713 discussion 829\u2013730","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"315_CR6","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.ophtha.2005.01.042","volume":"112","author":"R Valk van der","year":"2005","unstructured":"van der Valk R, Webers CAB, Schouten JSAG, Zeegers MP, Hendrikse F, Prins MH (2005) Intraocular pressure-lowering effects of all commonly used glaucoma drugs. Ophthalmology 112(7):1177\u20131185. doi: 10.1016\/j.ophtha.2005.01.042","journal-title":"Ophthalmology"},{"issue":"4","key":"315_CR7","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1177\/112067210701700407","volume":"17","author":"PA Kenigsberg","year":"2007","unstructured":"Kenigsberg PA (2007) Changes in medical and surgical treatments of glaucoma between 1997 and 2003 in France. Eur J Ophthalmol 17(4):521\u2013527","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"315_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/sj.eye.6702458","volume":"22","author":"SG Fraser","year":"2006","unstructured":"Fraser SG, Wormald RPL (2006) Hospital episode statistics and changing trends in glaucoma surgery. Eye 22(1):3\u20137. doi: 10.1038\/sj.eye.6702458","journal-title":"Eye"},{"issue":"3","key":"315_CR9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/00061198-200406000-00008","volume":"13","author":"DR Strutton","year":"2004","unstructured":"Strutton DR, Walt JG (2004) Trends in glaucoma surgery before and after the introduction of new topical glaucoma pharmacotherapies. J Glaucoma 13(3):221\u2013226. doi: 10.1097\/00061198-200406000-00008","journal-title":"J Glaucoma"},{"issue":"6","key":"315_CR10","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1016\/j.survophthal.2008.08.012","volume":"53","author":"GW Bean","year":"2008","unstructured":"Bean GW, Camras CB (2008) Commercially available prostaglandin analogs for the reduction of intraocular pressure: similarities and differences. Surv Ophthalmol 53(6):S69\u2013S84. doi: 10.1016\/j.survophthal.2008.08.012","journal-title":"Surv Ophthalmol"},{"issue":"12","key":"315_CR11","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1016\/s0161-6420(95)30798-1","volume":"102","author":"A Alm","year":"1995","unstructured":"Alm A, Stjernschantz J (1995) Effects on intraocular pressure and side effects of 0.005\u00a0% latanoprost applied once daily, evening or morning. Ophthalmology 102(12):1743\u20131752. doi: 10.1016\/s0161-6420(95)30798-1","journal-title":"Ophthalmology"},{"key":"315_CR12","doi-asserted-by":"publisher","first-page":"S361","DOI":"10.1016\/s0039-6257(01)00219-3","volume":"45","author":"M Sherwood","year":"2001","unstructured":"Sherwood M, Brandt J (2001) Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure. Surv Ophthalmol 45:S361\u2013S368. doi: 10.1016\/s0039-6257(01)00219-3","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"315_CR13","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0002-9394(01)01177-1","volume":"132","author":"Netland PA, Landry T, Sullivan EK, Andrew R, Silver L, Weiner A, Mallick S, Dickerson J, Bergamini MV, Robertson SM, Davis AA, Travoprost Study G","year":"2001","unstructured":"Netland PA, Landry T, Sullivan EK, Andrew R, Silver L, Weiner A, Mallick S, Dickerson J, Bergamini MV, Robertson SM, Davis AA, Travoprost Study G (2001) Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension. Am J Ophthalmol 132(4):472\u2013484","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"315_CR14","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1185\/030079907x178720","volume":"23","author":"P Denis","year":"2007","unstructured":"Denis P, Lafuma A, Khoshnood B, Mimaud V, Berdeaux G (2007) A meta-analysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapy. Curr Med Res Opin 23(3):601\u2013608. doi: 10.1185\/030079907x178720","journal-title":"Curr Med Res Opin"},{"issue":"8","key":"315_CR15","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1111\/j.1442-9071.2006.01237.x","volume":"34","author":"N Li","year":"2006","unstructured":"Li N, X-m Chen, Zhou Y, M-l Wei, Yao X (2006) Travoprost compared with other prostaglandin analogues or timolol in patients with open-angle glaucoma or ocular hypertension: meta-analysis of randomized controlled trials. Clin Exp Ophthalmol 34(8):755\u2013764. doi: 10.1111\/j.1442-9071.2006.01237.x","journal-title":"Clin Exp Ophthalmol"},{"issue":"11","key":"315_CR16","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1185\/030079905X65600","volume":"21","author":"S Holmstrom","year":"2005","unstructured":"Holmstrom S, Buchholz P, Walt J, Wickstrom J, Aagren M (2005) Analytic review of bimatoprost, latanoprost and travoprost in primary open angle glaucoma. Curr Med Res Opin 21(11):1875\u20131883. doi: 10.1185\/030079905X65600","journal-title":"Curr Med Res Opin"},{"issue":"8","key":"315_CR17","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1185\/03007990802273652","volume":"24","author":"CW Lee","year":"2008","unstructured":"Lee CW, Buckley F, Costello S, Kelly S (2008) A systematic review of the characteristics of randomised control trials featuring prostaglandins for the treatment of glaucoma. Curr Med Res Opin 24(8):2265\u20132270. doi: 10.1185\/03007990802273652","journal-title":"Curr Med Res Opin"},{"issue":"8","key":"315_CR18","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1097\/IJG.0b013e318166656d","volume":"17","author":"K Kashiwagi","year":"2008","unstructured":"Kashiwagi K, Tsumura T, Tsukahara S (2008) Long-term effects of latanoprost monotherapy on intraocular pressure in Japanese glaucoma patients. J Glaucoma 17(8):662\u2013666. doi: 10.1097\/IJG.0b013e318166656d","journal-title":"J Glaucoma"},{"issue":"Suppl 1","key":"315_CR19","doi-asserted-by":"publisher","first-page":"S107","DOI":"10.1016\/j.survophthal.2008.08.010","volume":"53","author":"CB Toris","year":"2008","unstructured":"Toris CB, Gabelt BT, Kaufman PL (2008) Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction. Surv Ophthalmol 53(Suppl 1):S107\u2013S120. doi: 10.1016\/j.survophthal.2008.08.010","journal-title":"Surv Ophthalmol"},{"issue":"Suppl 1","key":"315_CR20","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1016\/j.survophthal.2003.12.019","volume":"49","author":"JS Cohen","year":"2004","unstructured":"Cohen JS, Gross RL, Cheetham JK, VanDenburgh AM, Bernstein P, Whitcup SM (2004) Two-year double-masked comparison of bimatoprost with timolol in patients with glaucoma or ocular hypertension. Surv Ophthalmol 49(Suppl 1):S45\u2013S52. doi: 10.1016\/j.survophthal.2003.12.019","journal-title":"Surv Ophthalmol"},{"issue":"10","key":"315_CR21","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1136\/bjo.2007.128454","volume":"92","author":"Williams RD, Cohen JS, Gross RL, Liu CC, Safyan E, Batoosingh AL, Bimatoprost Study G","year":"2008","unstructured":"Williams RD, Cohen JS, Gross RL, Liu CC, Safyan E, Batoosingh AL, Bimatoprost Study G (2008) Long-term efficacy and safety of bimatoprost for intraocular pressure lowering in glaucoma and ocular hypertension: year 4. The British journal of ophthalmology 92(10):1387\u20131392. doi: 10.1136\/bjo.2007.128454","journal-title":"The British journal of ophthalmology"},{"issue":"Suppl 1","key":"315_CR22","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/S0039-6257(02)00301-6","volume":"47","author":"K Hedman","year":"2002","unstructured":"Hedman K, Watson PG, Alm A (2002) The effect of latanoprost on intraocular pressure during 2\u00a0years of treatment. Surv Ophthalmol 47(Suppl 1):S65\u2013S76","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"315_CR23","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0161-6420(98)91372-0","volume":"105","author":"Watson PG, Latanoprost Study Group","year":"1998","unstructured":"Watson PG, Latanoprost Study Group (1998) Latanoprost: two years\u2019 experience of its use in the United Kingdom. Ophthalmology 105(1):82\u201387","journal-title":"Ophthalmology"},{"issue":"4","key":"315_CR24","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/s0002-9394(00)00538-9","volume":"130","author":"Agis investigators","year":"2000","unstructured":"Agis investigators (2000) The advanced glaucoma intervention study (AGIS): 7. the relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 130(4):429\u2013440. doi: 10.1016\/s0002-9394(00)00538-9","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"315_CR25","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1111\/j.1442-9071.2006.01237.x","volume":"34","author":"N Li","year":"2006","unstructured":"Li N, Chen XM, Zhou Y, Wei ML, Yao X (2006) Travoprost compared with other prostaglandin analogues or timolol in patients with open-angle glaucoma or ocular hypertension: meta-analysis of randomized controlled trials. Clin Experiment Ophthalmol 34(8):755\u2013764. doi: 10.1111\/j.1442-9071.2006.01237.x","journal-title":"Clin Experiment Ophthalmol"},{"issue":"5","key":"315_CR26","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0002-9394(03)00098-9","volume":"135","author":"RK Parrish","year":"2003","unstructured":"Parrish RK, Palmberg P, Sheu WP (2003) A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study. Am J Ophthalmol 135(5):688\u2013703","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"315_CR27","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1111\/j.1600-0420.2007.00960.x","volume":"85","author":"OG Koz","year":"2007","unstructured":"Koz OG, Ozsoy A, Yarangumeli A, Kose SK, Kural G (2007) Comparison of the effects of travoprost, latanoprost and bimatoprost on ocular circulation: a 6-month clinical trial. Acta Ophthalmol Scand 85(8):838\u2013843. doi: 10.1111\/j.1600-0420.2007.00960.x","journal-title":"Acta Ophthalmol Scand"},{"key":"315_CR28","first-page":"246","volume":"6","author":"\u00dcN Yasemin","year":"2011","unstructured":"Yasemin \u00dcN, Tetiko\u011flu M, Yilmaz FSO, \u00d6zt\u00fcrk M, El\u00e7io\u011flu M (2011) Prostaglandin Analoglar\u0131n\u0131n Etkinli\u011fi. Journal of Glaucoma, 6(4), 246-249. Glokom-Katarakt 6:246\u2013249","journal-title":"Glokom-Katarakt"},{"issue":"11","key":"315_CR29","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1136\/bjo.2006.094326","volume":"90","author":"LB Cantor","year":"2006","unstructured":"Cantor LB, Hoop J, Morgan L, WuDunn D, Catoira Y (2006) Intraocular pressure-lowering efficacy of bimatoprost 0.03% and travoprost 0.004\u00a0% in patients with glaucoma or ocular hypertension. Br J Ophthalmol 90(11):1370\u20131373. doi: 10.1136\/bjo.2006.094326","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"315_CR30","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/IJG.0b013e3181af31d6","volume":"19","author":"G Kobelt","year":"2010","unstructured":"Kobelt G, Texier-Richard B, Buchholz P, Bron A, Renard JP, Rouland JF, Nordmann JP (2010) Treatment of glaucoma in clinical practice: 4-year results from a patient registry in France. J Glaucoma 19(3):199\u2013206. doi: 10.1097\/IJG.0b013e3181af31d6","journal-title":"J Glaucoma"},{"issue":"5","key":"315_CR31","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1089\/jop.2011.0051","volume":"27","author":"G Hollo","year":"2011","unstructured":"Hollo G, Thelen U, Teus MA, Quaranta L, Ferkova S, Babic N, Misiuk-Hojlo M, Mikropoulos DG, Kaluzny BJ, Kozobolis V, Januleviciene I, Kothy P, Camara C, Russo A, Krzyzanowska-Berkowska P, Cieslinska I, Stewart JA, Kristoffersen MS, Nelson LA, Stewart WC (2011) Long-term outcomes of prostaglandin analog versus timolol maleate in ocular hypertensive or primary open-angle glaucoma patients in Europe. J Ocul Pharmacol Ther 27(5):493\u2013498. doi: 10.1089\/jop.2011.0051","journal-title":"J Ocul Pharmacol Ther"},{"issue":"1","key":"315_CR32","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1755-3768.2010.01862.x","volume":"88","author":"Uusitalo H, Pillunat LE, Ropo A, Phase III SI","year":"2010","unstructured":"Uusitalo H, Pillunat LE, Ropo A, Phase III SI (2010) Efficacy and safety of tafluprost 0.0015\u00a0% versus latanoprost 0.005\u00a0% eye drops in open-angle glaucoma and ocular hypertension: 24-month results of a randomized, double-masked phase III study. Acta ophthalmol 88(1):12\u201319. doi: 10.1111\/j.1755-3768.2010.01862.x","journal-title":"Acta ophthalmol"},{"issue":"5","key":"315_CR33","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00417-002-0469-8","volume":"240","author":"C Costagliola","year":"2002","unstructured":"Costagliola C, Del Prete A, Verolino M, Antinozzi P, Fusco R, Parmeggiani F, Mastropasqua L (2002) Effect of 0.005% latanoprost once daily on intraocular pressure in glaucomatous patients not adequately controlled by beta-blockers twice daily: a 3-year follow-up. Experience and incidence of side effects in a prospective study on 76 patients. Graefe\u2019s Arch Clin Exp Ophthalmol\u00a0240(5):379\u2013386. doi: 10.1007\/s00417-002-0469-8","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"issue":"10","key":"315_CR34","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1167\/iovs.02-1281","volume":"44","author":"M Richter","year":"2003","unstructured":"Richter M, Krauss AH, Woodward DF, Lutjen-Drecoll E (2003) Morphological changes in the anterior eye segment after long-term treatment with different receptor selective prostaglandin agonists and a prostamide. Invest Ophthalmol Vis Sci 44(10):4419\u20134426","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"315_CR35","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1034\/j.1600-0420.2000.078001071.x","volume":"78","author":"A Alm","year":"2000","unstructured":"Alm A, Widengard I (2000) Latanoprost: experience of 2-year treatment in Scandinavia. Acta Ophthalmol Scand 78(1):71\u201376","journal-title":"Acta Ophthalmol Scand"},{"issue":"8","key":"315_CR36","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/IJG.0000000000000073","volume":"23","author":"I Riva","year":"2014","unstructured":"Riva I, Katsanos A, Floriani I, Biagioli E, Konstas AG, Centofanti M, Quaranta L (2014) Long-term 24-hour intraocular pressure control with travoprost monotherapy in patients with primary open-angle glaucoma. J Glaucoma 23(8):535\u2013540. doi: 10.1097\/IJG.0000000000000073","journal-title":"J Glaucoma"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10792-016-0315-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-016-0315-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-016-0315-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-016-0315-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T05:34:32Z","timestamp":1568266472000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10792-016-0315-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,9]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["315"],"URL":"https:\/\/doi.org\/10.1007\/s10792-016-0315-3","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"type":"print","value":"0165-5701"},{"type":"electronic","value":"1573-2630"}],"subject":[],"published":{"date-parts":[[2016,8,9]]}}}